Today's Veterinary Practice provides comprehensive information to keep every small animal practitioner up to date on companion animal medicine and surgery as well as practice building and management.
Issue link: http://todaysveterinarypractice.epubxp.com/i/715668
Pet owners don't like to see their dog suffer. So when they walk into your clinic with a dog that has a bacterial skin infection, they expect to receive the right solution to clear the infection quickly and on the fi rst try. Achieving fi rst-time treatment success for skin infections is also important to the veterinary community— because healthy pets mean happy clients. A recent study found that fi rst-time treatment success was the most important factor for veterinarians when selecting an antibiotic treatment, even over clinical performance and safety profi le. 1 Studies Support First-Time Treatment Success with CONVENIA ® (cefovecin sodium) The Food and Drug Administration (FDA) approved CONVENIA in 2008. Since then, CONVENIA has provided veterinarians with the only injectable antibiotic that achieves a high rate of fi rst-time treatment success and an assured 14-day course of therapy. The original effi cacy study to receive FDA approval showed that 86% of the dogs treated with CONVENIA only required one injection of the antibiotic to clear the skin infection. Zoetis is committed to continued research to demonstrate effi cacy and has conducted four additional studies to further support the rate of fi rst-time treatment success CONVENIA provides. Each study defi ned fi rst-time treatment success as an instance when a dog received only one injection of CONVENIA in a 30- day period. The injection is the clinical equivalent to 14 days of oral antibiotics. The population for each study varied from general practice patients to shelter dogs. The studies also had a wide range of participants, with the largest including more than 11,000 dogs. Each of the four studies showed that CONVENIA has a fi rst-time success rate higher than the original pivotal data study. The graph below provides a summary comparing each study. 2 "We were very pleased to learn in our effi cacy study for approval that 86% of dogs needed only one injection of CONVENIA to resolve their infection. Now, all these years later, we have additional data to support that this is still the case," said Amy Trettien, DVM, senior manager, U.S. Companion Animal Veterinary Speciality Operations, Zoetis. Why First-Time Treatment Success Matters A two-year-old female German Shorthaired Pointer was experiencing red, open lesions on her skin for one to two weeks. She presented to the veterinarian, was diagnosed with generalized pyoderma and treated with CONVENIA. 4 Within 24 hours, the skin was already beginning to clear. The photos demonstrate that after a single injection of CONVENIA, the pyoderma was resolved. This case study of fi rst-time treatment success illustrates one reason why 96% of pet owners would use CONVENIA again if recommended by their veterinarian. 5 First-Time Treatment Success: What You and Your Patients Deserve Date Data Source Type of Study Population of Dogs Dogs Receiving One Injection of CONVENIA Published in 2008 Cefovecin for Treating Canine Skin Infections 3 Prospective N=235 Pivotal Study 86% 2013 CAPNA Client Acceptance Trial Retrospective N=306 General Practice 96% 2013–2014 Give a Dog a Shot CONVENIA Shelter Program Retrospective N=40 Shelter 90% 2014–2015 You Call the Shots Reimbursement Data Analysis of Reimbursement Program N=11,519 All 90% 2014–2015 Speed of Response Prospective N=46 VCA General Practice Acute Moist Dermatitis 94%